FSD PHARMA B Aktie - Unternehmensdaten & Kurse - CA35954B4047 | MoneyPeak

FSD PHARMA B

Share · CA35954B4047 · HUGE · A3E2LR (XCNQ)

No Price

n/a

Share Float & Liquidity

Free Float 84,77 %

Shares Float 600.696,00

Shares Outstanding 708.609,00

Company Profile for FSD PHARMA B Share

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.

Get up to date insights from finAgent about FSD PHARMA B

Company Data

Name FSD PHARMA B

Company FSD Pharma Inc.

Symbol HUGE

Website https://www.fsdpharma.com

Primary Exchange

Frankfurt

WKN A3E2LR

ISIN CA35954B4047

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Zeeshan Saeed

Country Canada

Currency EUR

Employees 0,0 T

Address 199 Bay Street, M5L 1A9 Toronto

IPO Date 2018-05-29

Stock Splits

Date	Split
15.08.2024	1:65

Ticker Symbols

Name	Symbol
CSE LISTED	HUGE.CN
Frankfurt	0K9.F
NASDAQ	HUGE

More Shares

Investors who hold FSD PHARMA B also have the following shares in their portfolio:

EUROPEAN BANK FOR RECONSTRUCTION & DEVELOPMENT (UZS LINKED) AMTSNG 10.20% NTS 12/02/26 Bond

ORION OFFICE REIT Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025